I am sure that we would all prefer companies that we invest in to hit their target milestones on time every time . My experience over 20 years has been that they all miss deadlines for a raft of reasons as they depend on third parties and government authorities etc and when you add the unprecedented event we have experienced I am not surprised that any company experiences delays and in fa t would be surprised if that was not the case frankly .
The important thing is that the trials once they start are positive and whether they start this quarter or later if they succeed then it is a game changer of huge propositions . I am prepared to allow it the lead time and cut the board some slack regardless of any short term disappointment .Big picture view .
As for options my experiences have been negative but for ADN .If you want to invest in options then the benefit of leverage comes with the risk that they will expire if there are delays and the company does not meet the target deadlines . That is life and the boys that play know and wear that risk . I have options and would much rather the company strategy be more advanced into the trials but that is not the case and I have to suck it up . I am still confidant will start getting news flow shortly but the option expiry is fast approaching . I am sure the board is well aware of the option expiry and may well have significant options holdings themselves and are doing their best to progress the trials .
I am looking forward to the next 2-3 months . The SP will get some traction and it will come when we least expect it IMO .
IHL Price at posting:
5.3¢ Sentiment: Buy Disclosure: Held
